But that isnt effective if they cant absorb the nutrients or object to eating these foods
[18] FDA identified limitations in characterization data, potential immunogenicity concerns for injectable use, limited information for proposed routes, lack of established effectiveness for obesity, and insufficient long-term safety information
[5] In other words, the reduction in adipocytes of various sizes seen with AOD 9604 peptide in lab models may be due to a general suppression of lipid accumulation mechanisms
It falls under the S0 category of Non-Approved Substances, which is a catch-all classification for any pharmacological substance that isnt approved for human therapeutic use and is not addressed elsewhere on the list
Current NICE technology appraisals and the relevant UK Summaries of Product Characteristics (SmPCs), available via the Electronic Medicines Compendium (EMC), provide authoritative guidance on indications and eligibility